Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Accenture
Citi
Baxter
US Department of Justice
Healthtrust
Express Scripts
Merck
QuintilesIMS

Generated: June 20, 2018

DrugPatentWatch Database Preview

X-gen Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for X-GEN PHARMS INC, and what generic and branded alternatives to X-GEN PHARMS INC drugs are available?

X-GEN PHARMS INC has four approved drugs.



Summary for X-gen Pharms Inc
US Patents:0
Tradenames:4
Ingredients:4
NDAs:4

Drugs and US Patents for X-gen Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
X-gen Pharms Inc TRANEXAMIC ACID tranexamic acid INJECTABLE;INJECTION 201580-001 Jun 14, 2013 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
X-gen Pharms Inc LINCOMYCIN lincomycin hydrochloride INJECTABLE;INJECTION 201746-001 Jun 4, 2015 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
X-gen Pharms Inc HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride INJECTABLE;INJECTION 203110-001 Jun 29, 2015 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
X-gen Pharms Inc CLONIDINE HYDROCHLORIDE clonidine hydrochloride INJECTABLE;INJECTION 203167-002 Oct 29, 2013 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
US Department of Justice
Merck
Fuji
Deloitte
Dow
McKinsey
Fish and Richardson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.